Patent Term Application for COBENFY (xanomeline tartrate and trospium chloride), Patent No. 10,238,643
🏛 Food and Drug Administration (FDA)FDA-2025-E-0152
Documents
1
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
NoticeFeb 6, 2026
Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFYClosed on Aug 6, 2026